Medically Reviewed by Brunilda Nazario, MD on January 25, 2024

Get answers to your myelodysplastic syndromes questions

Meet Your Guide
photo of portrait
Maureen Ratliff
Advocate

Maureen Ratliff was diagnosed with myelodysplastic syndromes (MDS) in 2018, after some issues with her bone marrow. Soon after that, she started traveling from her home in Georgia to Nashville to hear talks from the MDS Foundation. She did some networking with health care professionals and joined clinical trials for 3 years. Maureen has a career in social work, so she was a natural to start a support group to help others who have MDS. She's awaiting a transplant.

Show Sources

SOURCES:

Maureen Ratliff, myelodysplastic syndromes patient and advocate, Ball Ground, GA.

Leukemia & Lymphoma Society: “The International Prognostic Scoring System.”

Blood: “WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).”

View privacy policy and trust info